Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Roivant
Roivant
Immunovant flashes the data that made Roivant want to reacquire it at a potentially hefty premium
Endpoints
Tue, 06/1/21 - 10:53 pm
Immunovant
Roivant
myasthenia gravis
thyroid eye disease
Roivant valued at $7B in blank-check merger, bucking SPAC slowdown
BioPharma Dive
Mon, 05/3/21 - 11:02 pm
Roivant
SPAC
M&A
The SPAC story departs from the script
EP Vantage
Wed, 03/10/21 - 10:42 am
Immunovant
Roivant
SPAC
Roivant Sciences founder to step down as CEO
Reuters
Mon, 01/25/21 - 11:10 am
Roivant
Phamra CEOs
Vivek Ramaswamy
As Urovant gears up for vibegron FDA decision, the biotech gets snapped up by Sumitovant Biopharma
Fierce Biotech
Fri, 11/13/20 - 12:50 pm
Urovant
Roivant
FDA
vibegron
overactive bladder
On Heels of the Sale of Five Vants, Roivant Launches New Company Lokavant
BioSpace
Mon, 01/13/20 - 11:46 pm
Roivant
Vivek Ramaswamy
clinical trials
Lokavant
Top Biopharma M&As in 2019
BioSpace
Fri, 01/3/20 - 10:06 am
M&A
Bristol-Myers Squibb
Celgene
AbbVie
Allergan
Roche
Spark Therapeutics
Novartis
The Medicines Company
Alkermes
Rodin Therapeutics
Sumitomo Dainippon
Roivant
The Roivant-Sumitomo Deal: $3 Billion, 5 Companies, $550 Million in Loans and an Option on 6 More...
BioSpace
Fri, 11/1/19 - 06:57 pm
M&A
Roivant
Vivek Ramaswamy
Sumitomo Dainippon
Roivant lines up $3B upfront in Sumitomo Dainippon deal
Fierce Biotech
Fri, 09/6/19 - 10:16 am
M&A
Roivant
Sumitomo Dainippon
Vivek Ramaswamy’s Urovant claims a big win in PhIII — but questions linger about a cheap generic and their branded rival
Endpoints
Tue, 03/19/19 - 10:30 am
Axovant
Alzheimer's disease
Roivant
Vivek Ramaswamy
Urovant
vibegron
urinary incontinence
A New Day, a New Vant. Roivant Launches Alyvant Ahead of J.P. Morgan 2019
BioSpace
Mon, 01/7/19 - 12:24 pm
Vivek Ramaswamy
Roivant
Alyvant
JPMHC 2019
Roivant launches lung-focused Respivant with phase 2 IPF drug
Fierce Biotech
Tue, 09/18/18 - 10:12 am
Roivant
Respivant Sciences
IPF
RVT-1601
Vivek Ramaswamy strikes again, this time launching a Beijing-based biotech player with a pipeline
Endpoints
Tue, 07/17/18 - 10:16 am
Vivek Ramaswamy
Roivant
China
Sinovant
Urovant seeks $150M IPO just a year after launch
Fierce Biotech
Mon, 07/16/18 - 10:16 pm
Urovant Sciences
IPOs
Merck
Roivant
overactive bladder
Dermavant inks $330M deal for GSK's phase 3-ready psoriasis drug
Fierce Biotech
Thu, 07/12/18 - 06:17 pm
GSK
Dermavant
Roivant
CSO
tapinarof
psoriasis
atopic dermatitis
Roivant CEO: Yes, we failed in Alzheimer’s, but we’re not giving up
Fierce Biotech
Sat, 11/11/17 - 11:04 am
Roivant
Alzheimer's disease
Vivek Ramaswamy
Biotech Wunderkind Raises $1.1 Billion To Fund Pharma Startups
Forbes
Wed, 08/9/17 - 11:16 am
startups
biotech
Roivant
Vivek Ramaswamy
Biotech minnow takes over GSK Alzheimer's drug
Pharmaphorum
Tue, 12/30/14 - 10:33 am
GSK
Alzheimer's disease
SB742457
Roivant
Pages
« first
‹ previous
1
2